ArticlePacing and clinical electrophysiology : PACE2026
Modified Anatomical Ablation Strategy for Mitral Isthmus.
Article in Pacing and clinical electrophysiology : PACE, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundDurable mitral isthmus (MI) block remains challenging in persistent atrial fibrillation (AF) ablation. Ethanol infusion into the vein of Marshall (EI-VOM) enhances efficacy, but the minimal endocardial ablation extent post-EI-VOM is undefined.
methodsThis prospective study (June 2024-March 2025) enrolled 35 persistent AF patients undergoing first-time ablation: EI-VOM (11.10 ± 2.24 mL ethanol), bilateral pulmonary vein isolation (PVI), linear ablations, and stepwise MI ablation. Endpoints included acute MI block, lesion requirements, and 6-month sinus rhythm (SR) maintenance.
resultLeft PVI demonstrated significantly shorter ablation time versus right-sided PVI (10.94 ± 5.31 min vs. 18.77 ± 7.27 min, p < 0.01), while acute MI block was achieved in 88.6% (31/35) of patients with 5.03 ± 4.51 endocardial lesions-notably fewer in smaller left atria (diameter <45 mm: 4.1 ± 3.9 vs. ≥45 mm: 6.8 ± 5.1 lesions, p = 0.03). EI-VOM enabled 90% of MI blocks with partial endocardial ablation. SR maintenance reached 91.4% (3-month) and 88.5% (6-month), showing no correlation with MI block or clinical variables (p > 0.05), with zero major complications recorded.
conclusionsEI-VOM synergizes with partial endocardial ablation for MI block, particularly in non-dilated left atria (<45 mm). Adjunctive coronary sinus ablation is essential for dilated atria. High mid-term SR stability (88.5%) supports strategy efficacy, though non-anatomical factors influence recurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.